By Counterforce Health Team in Kanuma (sebelipase alfa) —

Do You Qualify for Kanuma (Sebelipase Alfa) Coverage by UnitedHealthcare in New Jersey? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Kanuma Coverage in New Jersey

Yes, you can get Kanuma (sebelipase alfa) covered by UnitedHealthcare in New Jersey if you have confirmed LAL-D diagnosis. UnitedHealthcare requires prior authorization through OptumRx with specific clinical documentation. First step today: Gather your LAL enzyme test results and LIPA gene sequencing, then have your specialist submit a prior authorization request via the UnitedHealthcare Provider Portal. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) through Maximus Federal Services provides binding external review within 45 days.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible" - Your Action Plan
  4. If "Possibly Eligible" - Tests to Request
  5. If "Not Yet" - Alternative Strategies
  6. If Denied - New Jersey Appeal Path
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & How to Fix Them
  9. Costs & Patient Assistance Options
  10. FAQ: New Jersey Kanuma Coverage

How to Use This Decision Tree

This guide walks you through UnitedHealthcare's specific requirements for Kanuma (sebelipase alfa) coverage in New Jersey. Follow the eligibility questions below to determine your best path forward. Each section includes actionable next steps, required documents, and official links.

Important: Kanuma is the only FDA-approved enzyme replacement therapy for lysosomal acid lipase deficiency (LAL-D). There are no step therapy alternatives, making your case stronger for medical necessity appeals.

Eligibility Triage: Do You Qualify?

Likely Eligible ✅

You have:

  • Confirmed LAL-D diagnosis with enzyme testing (LAL activity <0.59 nmol/punch/h in dried blood spot)
  • LIPA gene sequencing showing pathogenic variants
  • Clinical evidence of disease severity (elevated liver enzymes, hepatomegaly, dyslipidemia)
  • Prescription from a metabolic or genetic disease specialist

Next step: Proceed to the action plan below.

Possibly Eligible ⚠️

You have:

  • Suspected LAL-D with some clinical features (unexplained hepatomegaly, persistent dyslipidemia)
  • Elevated liver enzymes without clear cause
  • Family history of similar symptoms
  • But missing definitive diagnostic testing

Next step: Request additional testing (see section below).

Not Yet ❌

You have:

  • No confirmed LAL-D diagnosis
  • Normal LAL enzyme activity
  • Alternative explanations for symptoms
  • No specialist evaluation

Next step: Discuss with your physician about alternative diagnoses and treatments.

If "Likely Eligible" - Your Action Plan

Document Checklist

Before your specialist submits the prior authorization:

Required Clinical Documentation:

  • LAL enzyme activity test results (dried blood spot preferred)
  • LIPA gene sequencing report with pathogenic variants identified
  • Liver function tests showing elevated ALT/AST
  • Lipid panel demonstrating dyslipidemia pattern
  • Growth charts (for pediatric patients)
  • Imaging showing hepatomegaly/splenomegaly
  • Specialist consultation notes

Submission Process:

  1. Provider submits PA via UnitedHealthcare Provider Portal
  2. OptumRx reviews within 72 hours (standard) or 24 hours (expedited)
  3. Decision notification sent to both patient and provider
  4. If approved: Kanuma ships from specialty pharmacy
  5. If denied: Appeal options begin immediately
Tip: Ask your specialist to request expedited review if delays could worsen your condition, especially for pediatric patients.

If "Possibly Eligible" - Tests to Request

Essential Diagnostic Tests

Ask your physician to order:

  1. Dried Blood Spot LAL Activity Test
    • Most specific current assay using Lalistat-2 inhibitor
    • Results <0.59 nmol/punch/h indicate LAL-D
    • Available through reference laboratories
  2. LIPA Gene Sequencing
    • Confirms diagnosis and identifies disease-causing variants
    • Helps predict disease severity and progression
    • Required for definitive diagnosis
  3. Comprehensive Metabolic Panel
    • Liver enzymes (ALT, AST, alkaline phosphatase)
    • Total cholesterol, LDL-C, HDL-C, triglycerides
    • Baseline values for monitoring treatment response

Timeline to Re-apply

  • Test results: 2-4 weeks typically
  • Specialist consultation: Schedule within 2 weeks of results
  • PA submission: Within 1 week of specialist visit
  • Total timeline: 5-7 weeks from initial testing

If "Not Yet" - Alternative Strategies

Supportive Management Options

While not substitutes for enzyme replacement therapy, these may help manage symptoms:

  • Lipid-lowering medications (statins, ezetimibe) for cholesterol management
  • Nutritional support and dietary modifications
  • Regular monitoring of liver function and growth
  • Liver transplant evaluation in end-stage cases (rare)

Preparing for Exception Requests

If your case doesn't fit standard criteria:

  1. Document unique circumstances in detail
  2. Gather supporting literature for off-label or compassionate use
  3. Request specialist letter explaining medical necessity
  4. Consider clinical trial enrollment if available

If Denied - New Jersey Appeal Path

Level 1: Internal Appeal (UnitedHealthcare)

Timeline: 180 days from denial date How to submit: UnitedHealthcare member portal or written request Processing time: 30 days (standard), 72 hours (expedited)

Required documents:

  • Original denial letter
  • Additional clinical documentation
  • Specialist letter addressing denial reasons
  • Updated lab results or imaging

Level 2: Peer-to-Peer Review

When to request: After first-level denial Process: Your specialist speaks directly with UnitedHealthcare medical director Timeline: Usually scheduled within 5 business days Success rate: Higher with well-prepared clinical arguments

Level 3: New Jersey External Review (IHCAP)

Administered by: Maximus Federal Services Timeline: File within 4 months of final internal denial Processing: 45 days (standard), 48 hours (expedited) Cost: Free to patient Decision: Binding on UnitedHealthcare

How to file:

  1. Submit electronically at njihcap.maximus.com
  2. Include final denial letter and medical records
  3. Provide consent if filed by provider/advocate
  4. Contact: 888-866-6205 or [email protected]
Note: New Jersey's external review success rate is approximately 50% for medical necessity cases, higher with strong clinical documentation.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all new starts UnitedHealthcare Provider Portal UHC PA Requirements
Diagnosis Confirmation LAL enzyme + genetic testing Specialist consultation notes FDA labeling requirements
Specialist Prescription Metabolic or genetic disease specialist Provider credentials in PA OptumRx criteria
Age-Based Dosing Infants: 1-3 mg/kg weekly; Others: 1 mg/kg q2 weeks FDA prescribing information Kanuma FDA Label
Site of Care Infusion center or home health Prior authorization specifies UHC medical policy
Appeals Deadline 180 days internal, 4 months external Denial letter instructions NJ IHCAP regulations

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documents
"Not medically necessary" Provide enzyme/genetic test results showing definitive LAL-D Lab reports, specialist letter
"Experimental/investigational" Cite FDA approval for LAL-D (2015) FDA labeling, prescribing information
"Inadequate trial of alternatives" Document that no alternatives exist for LAL-D Medical literature, specialist attestation
"Incorrect dosing" Align with FDA-approved weight-based dosing Dosing calculations, growth charts
"Missing clinical documentation" Submit complete diagnostic workup All test results, imaging, specialist notes

Costs & Patient Assistance Options

Manufacturer Support Programs

Alexion Patient Access Program:

  • Financial assistance for eligible patients
  • Copay support for commercial insurance
  • Free drug program for uninsured patients
  • Contact: alexionaccessnavigator.com

Foundation Grants

Several patient assistance foundations provide grants for rare disease medications:

  • National Organization for Rare Disorders (NORD)
  • Patient Access Network Foundation
  • Good Days (formerly Chronic Disease Fund)
From our advocates: "One family in New Jersey successfully reduced their Kanuma copay from $2,400/month to $50/month by combining manufacturer copay assistance with a foundation grant. The key was applying early—before starting treatment—and working with the specialty pharmacy to coordinate benefits."

New Jersey State Programs

  • NJ FamilyCare (Medicaid expansion) covers Kanuma with prior authorization
  • Pharmaceutical Assistance to the Aged and Disabled (PAAD) may provide additional copay support
  • Contact NJ Department of Human Services: 1-800-356-1561

FAQ: New Jersey Kanuma Coverage

How long does UnitedHealthcare prior authorization take in New Jersey? Standard review takes up to 72 hours; expedited review (for urgent cases) takes up to 24 hours. OptumRx processes most specialty drug PAs within this timeframe.

What if Kanuma is non-formulary on my UnitedHealthcare plan? Request a formulary exception with your specialist's support. Document that no formulary alternatives exist for LAL-D, as Kanuma is the only FDA-approved treatment.

Can I request an expedited appeal in New Jersey? Yes, both UnitedHealthcare and New Jersey's IHCAP offer expedited reviews when delays could seriously jeopardize your health. Pediatric patients often qualify for expedited processing.

Does step therapy apply if I've tried treatments outside New Jersey? Document all prior treatments regardless of location. Since no alternatives exist for LAL-D, step therapy requirements should not apply, but comprehensive documentation strengthens your case.

What happens if I move from New Jersey to another state? Your UnitedHealthcare coverage continues, but state-specific external review processes may differ. Contact your new state's insurance department for local appeal procedures.

How much does Kanuma cost without insurance? Retail prices range from approximately $9,981 per 10 mL vial, with annual costs potentially reaching $890,000-$4.9 million depending on patient weight and dosing frequency.

When to Contact New Jersey Regulators

If you experience problems with UnitedHealthcare's appeals process, contact:

New Jersey Department of Banking and Insurance

  • Consumer Hotline: 1-800-446-7467
  • IHCAP-specific questions: 1-888-393-1062
  • Online: nj.gov/dobi

File a complaint if:

  • Appeals deadlines aren't met
  • Required documents aren't processed
  • Decisions appear to contradict medical evidence
  • Communication is inadequate or misleading

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating evidence-backed, payer-specific rebuttal letters. Our platform identifies denial reasons and drafts targeted responses aligned with each plan's criteria, significantly improving approval rates for complex medications like Kanuma.

For additional support with your Kanuma appeal, Counterforce Health can help you build a comprehensive case that addresses UnitedHealthcare's specific requirements and New Jersey's regulatory framework.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual circumstances and plan details. Always consult with your healthcare provider and insurance plan directly for personalized guidance. Verify all forms, deadlines, and contact information with official sources before taking action.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.